1 -4(32/1)2020 — Аbrаmyan А. А., Rahimbayeva G. S. — FRONTO-TEMPORAL DEMENTIA

FRONTO-TEMPORAL DEMENTIA

Аbrаmуan А. А.- Andijan State medical institute

Rahimbayeva G. S. – Andijan State medical institute

Nasirdinova N. А. – Andijan State medical institute

 Urinova G.G. – Andijan State medical institute

Resume

Frontotemporal dementia (FTD) is a collective clinical and diagnostic category used to describe a number of dementia syndromes associated with focal atrophy of the medial, orbitofrontal cortex and anterior temporal lobes. According to epidemiological studies, FTD ranks second among dementiatingprocesses at a young age after Alzheimer’s disease (AD). The prevalence of FTD is approximately 15 cases per 100 thousand of the population aged 45-54 years. The FTD syndrome can be clinically and pathoanatomically combined with motor neuron
disease, as well as with a number of extrapyramidal motor diseases. Approximately 10% of persons with FTD have clinical and neurophysiological manifestations of motor neuron disease, while the same number of patients with this pathology demonstrate behavioral and / or aphatic disorders sufficient to establish the diagnosis of FTD. Of the extrapyramidal diseases with FTD, corticobasal degeneration and progressive supranuclear palsy are most often comorbid.

Key words: dementia, temporal lobe dementia, frontotemporal dementia.

First page

10

Last page

13

For citation: Аbrаmyan А. А., Rahimbayeva G. S., Nasirdinova N. А., Urinova G.G., Fronto-temporal dementia//NewDAy in  Medicine 4(32)2020 10-13  https://cutt.ly/Av49JJq

List of References

  1. Васенинa Е.Е., Верютна Н.И., Левин О.С. Hаучная статья на тему “Современные представления о ди’иностике и лечении лобно-височной леменции” Современная терапия в психиат­рии и неврологии №3; РМАПО, Москва, 2015 год; стр. 26-34 2. Васенина Е.Е., Левин О.С. Первичные прогрессирующие афа­зии // Журнал неврологии и психиатрии. – 2014. -Т. 6, № 2. – С. 3-12. 
  2. Гришина Д.А., Захаров В.В., Яхно Н.Н. Когнитивнаые нарушения при повеленческой форме лобно-височной демевдии НЕВРОЛОГИЧЕСКИЙ ЖУРНАЛ, № 6, 2016, научная ста­тья, стр 330-337
  3. Захаров В.В., Вознесенская Т.Г. Нервно-псч^ические нарушения: диапюстические тесты. М.: Медпресс-информ; 2013. Кадыков А.С., Калашникова Л.А., Шахпаронова Н.В., Каши- На Е.М., Егорова А.В., Пильщикова И.К.Первичная прогрес­сирующая афазия. Атмосфера.    Нервные болезни. 2005; 4: 33-6.
  4. Левин О.С. Кошитивныенарушения в неврологической прак­тике.- М.: МЕДпресс-информ, 2013. – 272 с.
  5. Степкина Д.А., Захаров В.В., Ясно Н.Н. Лобно-височная дегенерация (обзор литературы и собственные наблюления). Доктор.Ру. 2013; (5): 44-50.
  6. Степкина Д.А., Захаров В.В., Яхно Н.Н. Некопн-пивные не- рвио-психические нарушения при сивдроме первичной про­грессирующей афазии.        Неврологический журнал. 2014; 19 (6): 17-22.
  7. Степкина Д.А., Захаров В.В., Яхно Н.Н. Сивдром  первичной прогрессирующей афазии. Неврологический журнал №5; 2014; 22-28
  8. Яхно Н.Н., Захаров В.В., Локшина А.Б., Коберская Н.Н., Мхитарян Э.А. Демевдии. Руководство для врачей. М.: МЕД- пресс-информ; 2010,
  9. Яхно Н.Н., Штульман Д.Р. Болезни нервной системы; Руко­водство для врачей; Москва “Мелицина” 2003
  10. Bonner M.F., Ash S., Grossman M. The new classification of primary progressive aphasia into semantic, logopenic, or non- fluent/agrammatic variants. Curr. Neurol. Neurosci. 2010; 10: 484­90.
  11. Boxer A., Lipton A.M., Womack K. et al. An open-label study of Memantine treatment in 3 subtypes of frontotem-poral lobar degeneration. Alzheimer Dis Assoc Disord.2009; 23: 211-7.
  12. Cerami C., Cappa S.F. The behavioral variant of frontotemporal dementia: linking neuropatholcmogy to social cognition// Neurol Sci. – 2013. – Vol. 34. – P. 1267-1274. “
  13. Сhare L., Hodges J.R., Leyton C.E., et al. New criteria for frontotemporal dementia syndromes: clinical and pathological diagnostic implications // J Neurol Neurosurg Psychiatry. – 2014. -Vol. 85. – P. 866-871.
  14. Chow T.W. What are the different initial presentations of frontotemporal dementia? // J Mol Neu-rosci. – 2011. – Vol. 45. – P. 710-712.,
  15. Coleman L.W., Digre K.B., Stephenson G.M., Townsend J.J. Autopsy-proven, sporadic pick disease with onset at age 25 years. Arch. Neurol. 2002; 59 (5): 856-59.
  16. Ferrari R., Hernandez D.G., Nalls M.A., et al. Frontotemporal dementia and its subtypes: a genome-wide association study // Lancet Neurol. – 2014. – Vol. 13. – P. 686-699.
  17. Gorno-Tempini M.L., Brambati S.M., Ginex V.et al. The logopenic/phonological variant of primary progressive aphasia. Neurology. 2008; 71: 1227-34.
  18. Gorno-Tempini M.L., Dronkers N.F., Rankin K.P. et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann. Neurology. 2004; 55: 335-46.
  19. Gorno-Tempini M.L., Hillis A.E., Weintraub S. et al. Classification of primary progressive aphasia and its variants. Neurology. 2011; 76:1006-14.
  20. Grossman M. Primary progressive aphasia: clinicopathological correlations. Nat. Rev. Neurol. 2010; 6: 88-97.
  21. Johnson N.A., Rademaker A., Weintraub S. et al. Pilot trail of memantine in primary progressive aphasia. Alzheimer Dis. Assoc. Disord. 2010; 24: 308.
  22. Kertesz A., Morlog D., Light M. et al. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement. Geriatr. Cogn. Disord. 2008; 25: 178-85.
  23. Laforce R. Behavioral and language variants of frontotemporal dementia: a review of key symptoms // Clinical Neurology and Neurosurgery. -2013. – Vol. 115. – P. 2405-2410.
  24. Lovestone S., Philpot M., Connell J., Lantos P., Powell J., Russ C. et al. Genetics, molecular biology, neuropathology and pheno-type of frontal lobe dementia. Br. J. Psych. 2002; 180: 455­60.
  25. Lund and Manchester Groups. Clinical and neuropathological criteria for fronto-temporal degeneration. J. Neurol. Neurosurg. Psychiatry. 1994; 57 (4): 416-8.
  26. Mesulam M.M. Slowly progressive aphasia without generalized dementia. Ann. Neurol. 1982; 11: 592-8.
  27. Mesulam M.M., Wieneke C., Rogalski E. Quantitative template for subtyping primary progressive aphasia. Arch. Neurol. 2009; 66: 1545-51.
  28. Mesulam M.M., Wieneke C., Thompson C. et al. Quantitative classification of primary  progressive aphasia at early and mild impairment stages. Brain. 2012; 135: 1537-53.
  29. Neary D., Snowden J.S., Gustafson L. et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998; 51: 1546-54.
  30. Onyike C.U., Diehl-Schmid J. The epidemiology of frontotemporal dementia // Int Rev Psychiatry. – 2013. – Vol. 25, № 2. – P 130­137.
  31. Paulos J.P., Massano J. Clinical, genetic and neuropathological features of frontotemporal dementia: an update and guide // Acta Med Port. – 2013. – Vol. 26, № 4. – P. 392-401.
  32. Pressman P.S., Miller B.L. Diagnosis and management of behavioral variant frontotemporal dementia // Biol Psychiatry. – 2014. – Vol. 75. -P. 574-581.
  33. Rabinovici G.D., Jagust W.J., Furst A.J. et al. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia. Ann. Neurol. 2008; 64: 388-401.
  34. Rascovsky K., Hodges J.R., Knopman D., etal. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia // Brain. – 2011. – Vol. 134. – P. 2456­2477.
  35. Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J. et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011; 134 (Pt. 9): 2456-77.
  36. Seelaar H., Rohrer J.D., Pijnenburg Y.A., Fox N.C., van Swieten J.C. Clinical, genetic and pathological heterogeneity of fronto­temporal dementia: a review. J. Neurol. Neurosurg. Psychiatry. 2011; 82: 476-86. 
БухМИ-4-32-2020-тиббиётда-янги-кун

file

download